CHONGQING KANGLE PHARMACEUTICAL CO., LTD

Chongqing Kangle Pharmaceutical Co.,Ltd.was established in 1988,specializing in the research,development,production,and sales of APis and advanced pharmaceutical intermediates. The company is located in the Chongqing Changshou National Chemical Industry Park,with an area of104000m2.It has been recognized as a national high-tech enterprise,a national intellectual property advantage enterprise,a provincial-level enterprise technology center,a specialized,refined,unique, and innovative' enterprise in Chongqing,and one of the first pilot units for commercal secret protection in Chongqing.And also with the honor to participate in establishment of the national drug standards& supplyment for the national drug standards,Kangle's APls have been certfied by U.S.FDA, E.U.CEP,WHO(PQ),PMDA in Japan,KDMF in Korea,etc,and also has registered multiple APl products inwarious countries and regions woridwide Kangle's products include antimalarial,anti-mheumatic,cardiovascular,and antibacterial drugs, as well as adivanced pharmaceutical intermediates.Notably,Kanige'sAPls such as hydroxychloro- quine sulfate,chloroquine phosphate,cilostazol,and sulfadiazine are among the leading domestic brands.About50% of the company's products are exported to countries and regions such as the UnitedStates,Europe,Japan,SouthAmerica,Southeast Asia and etc.The company take the quality philoso- phy of'dedication,precision,and excellence,focusing on a2+Nplan for specaltyAPls(4-aminopyrim- idine quinoline APls,sulfonamide APis,and N: new and specal APis,and advanced pharmaceutical intermediates).